Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 09:51:57 16/06/2026 pm IST			5-day change	1st Jan Change
449.75 ^USD	-0.16%		+0.74%	-0.95%

11/06	Vertex's Late-Stage Clinical Data of Casgevy Deliver Crisis-Free, Transfusion-Free Results in Kids With Blood Disorders	MT
11/06	Vertex Pharmaceuticals Incorporated Presents New Data on Casgevy and Announces Additional Global Regulatory Submissions	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	1,04,849	1,03,707	1,15,026	1,14,329	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	-0.61%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	1,08,418	1,01,545	97,195	92,828
Change	-	31.13%	47.8%	4.23%	11.09%	-6.34%	-4.28%	-4.49%
P/E Ratio	24.4x	22.5x	29.3x	-194x	29.6x	25.8x	22.9x	19.6x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.17x	4.3x	3.63x
PEG	-	0.5x	3.51x	2x	-0x	1.8x	1.8x	1.2x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	8.77x	8.01x	7.22x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	7.79x	6.81x	5.86x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	17.6x	14.6x	12.2x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	18.3x	15.4x	12.7x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	20.9x	18.9x	16.4x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.78%	5.29%	6.08%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.49	19.71	23.03
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,038	14,267	15,840
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,782	6,651	7,618
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,554	6,319	7,333
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,451	5,053	5,979
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-12,785	-17,134	-21,501
Reference price ²	219.60	288.78	406.89	402.70	453.36	450.46	450.46	450.46
Nbr of stocks (in thousands)	2,54,252	2,56,691	2,57,683	2,57,529	2,53,719	2,53,805	-	-
Announcement Date	26/01/22	07/02/23	05/02/24	10/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	25.76x	7.79x	17.56x	-.--%	11TCr
ELI LILLY AND COMPANY	33.05x	12.01x	24.74x	0.6%	1,00700Cr
JOHNSON & JOHNSON	25.19x	5.81x	15.79x	2.26%	57TCr
ABBVIE INC.	27.13x	6.62x	13.53x	3.1%	39TCr
ROCHE HOLDING AG	17.5x	4.32x	10.61x	3.07%	33TCr
NOVARTIS AG	20.98x	5.43x	13.17x	2.95%	28TCr
ASTRAZENECA PLC	22.23x	4.65x	13.18x	1.88%	28TCr
NOVO NORDISK A/S	12.63x	4.73x	9.67x	3.97%	20TCr
AMGEN INC.	22.79x	6.1x	10.65x	2.88%	19TCr
GILEAD SCIENCES, INC.	-44.54x	5.38x	29.66x	2.61%	15TCr
Average	16.27x	6.28x	15.86x	2.33%	35TCr
Weighted average by Cap.	22.49x	7.42x	17.26x	2.05%